Govt clears Corbevax as Covid-19 booster dose for adults vaccinated with Covaxin, Covishield Health Ministry's approval is based on the recommendations made by the NTG Corbevax is currently being used to inoculate children in the age group of 12 to 14 years under the COVID-19 immunisation programme.
CORBEVAX has become the first vaccine in India to get DCGI approval for COVID-19 booster dose. People who are 18 years & above & have already taken two doses of either COVISHIELD or COVAXIN can now receive a dose of CORBEVAX. The vaccine can be taken after 6 months of two doses of Covaxin or Covishield vaccines for restricted use in emergency situation.
India has entered a new era in the case of Covid. And in this new era, children of 12 to 14 years have started getting the vaccine of Covid. Children are being given the Corbevax vaccine made in India, which has been developed by Hyderabad-based company, Biological E. In the trial, this vaccine has been found to be up to 90 percent effective and it is also capable of defeating beta and delta variants of corona.